RxDoctor Payments Data

Raneat Cohen

Corneal and Contact Management · Columbia, MONPI 1407017155

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for corneal and contact management clinicians in MO, where the typical reported total is $993.

$540in general payments, 2019–2025

Across 17 payments — averaging $31.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$100
  • Sun Pharmaceutical Industries Inc.$86
  • Shire North American Group Inc$85
  • Johnson & Johnson Vision Care, Inc.$76
  • Alcon$69
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$46
  • plus $78 from 3 others

What the payments were for

  • Food & beverage$540100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$540 in reported general payments places this provider in the 45th percentile of 22 corneal and contact management providers in Missouri.

See all corneal and contact management providers in Missouri

Medicare billing

Part B allowed, 2024
$30,873
Medicare patients
152
Services billed
403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost66$1,583
ErythromycinErythromycin Base19$245

Paid to pharmacies, not to this prescriber.

Other corneal and contact management in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →